◆英語タイトル：Xbrane Biopharma AB (XBRANE) - Financial and Strategic SWOT Analysis Review
Xbrane Biopharma AB (Xbrane), formerly Xbrane Bioscience AB is a biopharmaceutical company that develops and manufactures complex generic products. The company’s product portfolio includes biosimilars and long acting injectables developed for people suffering from critical diseases. It combines its proprietary microsphere and protein production technology platforms to develop and produce generics drugs for controlled release of the active substance through encapsulation in microspheres. The company’s products find application in treating diseases across various therapeutic areas including acromegaly and neuroendocrine tumours, prostate cancer, endometriosis and uterine fibroids; age-related macular degeneration and macular oedema, among others. Xbrane is headquartered in Stockholm, Sweden.
Xbrane Biopharma AB Key Recent Developments
Feb 22,2019: Xbrane Biopharma releases Year-end report for 2018
Feb 15,2019: Xbrane Biopharma informs about presentations where the company participates on February 19
Feb 14,2019: Martin Amark, CEO for Xbrane Biopharma, becomes head of IR for the company
Nov 16,2018: Xbrane Biopharma releases interim report for the third quarter of 2018
This comprehensive SWOT profile of Xbrane Biopharma AB provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Xbrane Biopharma AB including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Xbrane Biopharma AB – Key Information
Xbrane Biopharma AB – Overview
Xbrane Biopharma AB – Key Employees
Xbrane Biopharma AB – Key Employee Biographies
Xbrane Biopharma AB – Key Operational Heads
Xbrane Biopharma AB – Major Products and Services
Xbrane Biopharma AB – History
Xbrane Biopharma AB – Company Statement
Xbrane Biopharma AB – Locations And Subsidiaries
Xbrane Biopharma AB – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Xbrane Biopharma AB – Business Description
Xbrane Biopharma AB – Corporate Strategy
Xbrane Biopharma AB – SWOT Analysis
SWOT Analysis – Overview
Xbrane Biopharma AB – Strengths
Xbrane Biopharma AB – Weaknesses
Xbrane Biopharma AB – Opportunities
Xbrane Biopharma AB – Threats
Xbrane Biopharma AB – Key Competitors
Section 3 – Company Financial Performance Charts
Xbrane Biopharma AB – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Xbrane Biopharma AB, Key Information
Xbrane Biopharma AB, Key Ratios
Xbrane Biopharma AB, Share Data
Xbrane Biopharma AB, Major Products and Services
Xbrane Biopharma AB, History
Xbrane Biopharma AB, Key Employees
Xbrane Biopharma AB, Key Employee Biographies
Xbrane Biopharma AB, Key Operational Heads
Xbrane Biopharma AB, Other Locations
Xbrane Biopharma AB, Subsidiaries
Xbrane Biopharma AB, Key Manufacturing facilities
Xbrane Biopharma AB, Key Competitors
Xbrane Biopharma AB, SWOT Analysis
Xbrane Biopharma AB, Ratios based on current share price
Xbrane Biopharma AB, Annual Ratios
Xbrane Biopharma AB, Interim Ratios
Capital Market Ratios
List of Figures
Xbrane Biopharma AB, Performance Chart
Xbrane Biopharma AB, Ratio Charts
| ★海外企業調査レポート[Xbrane Biopharma AB (XBRANE)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら